abstract: Cyclic adenosine 3
Introduction
Cyclic adenosine 3 ′ -5 ′ -monophosphate (cAMP) is a second messenger highly involved in the modulation of human first-trimester trophoblast functions. In particular, the nucleotide induces cytotrophoblast differentiation to both syncytiotrophoblast and extravillous trophoblast (EVT) (Bernatchez et al., 2003; Higuchi et al., 2003; Kudo et al., 2004) , and is implicated in the control of syncytiotrophoblast secretory activity as well as of EVT cell proliferation, migration and invasiveness (Qu and Thomas, 1993; Sawai et al.,1996; Zygmunt et al., 1998; McKinnon et al., 2001) . We have recently confirmed the cAMP involvement in the modulation of first-trimester human EVT functions, using the HTR-8/ SVneo cell line, which represents a good model of this tissue. Indeed prostaglandin E 2 (PGE 2 ) and forskolin (FSK), two compounds that greatly enhance cAMP concentration, inhibit cell proliferation and migration, whereas somatostatin, which reduces PGE 2 -and FSK-enhanced cAMP levels, stimulates these cellular responses (Biondi et al., 2006 (Biondi et al., , 2008 . We also found that somatostatin decreases stimulated cAMP levels and enhances proliferation in JAR cells (Biondi et al., 2008) , another common model of human early trophoblast.
It has long been known that cAMP, once produced inside the cell, can reach the extracellular medium. Although this process was described approximately four decades ago and then identified in most cell types and tissues (Jackson and Raghvendra, 2004; Chiavegatti et al., 2008) , little is known about both the egress mechanism and its physiological significance.
Evidence has been obtained indicating that cAMP outflow is mediated by multispecific membrane transporters belonging to the ABC family; among these, the multidrug resistance protein (MRP) subfamily seems to be of particular importance in mediating cyclic nucleotide efflux (Wielinga et al., 2003) . It has been proposed that extracellular cAMP may contribute to regulation of the intracellular nucleotide levels or provide for the production of the autocrine/ paracrine signalling molecule adenosine (Hofer and Lefkimmiatis, 2007; Chiavegatti et al., 2008) . cAMP could also enter the circulation, there representing a stable source of the short-life adenosine (Jackson and Raghvendra, 2004) . Extracellular cAMP may have modulatory effects per se; indeed, although specific receptors for this nucleotide have been characterized only in primitive organisms (Lee et al., 2005) , their presence has been reported in mammalian cells too (Sorbera and Morad, 1991) .
Only a few investigations have been carried out on cAMP outflow from fetal and/or maternal tissues. For example, Grealy and Sreenan (1999) found an efflux of cAMP from preimplantation cattle blastocysts and proposed that the nucleotide may have a role in embryo-maternal signalling and/or in the regulation of embryonic cell proliferation. cAMP egress was also evidenced in bovine oviduct cells, where it could regulate sperm function, fertilization, and early embryo development (Cometti et al., 2003) . To our best knowledge, no report exists regarding cAMP efflux from human trophoblast; however, this tissue could indeed secrete cAMP, since the expression of putative cyclic nucleotide transporters has been demonstrated in human placenta and cultured trophoblast cells (Meyer zu Schwabedissen et al., 2005; Evseenko et al., 2006) .
In the present study we utilized HTR-8/SVneo cell line to verify whether intracellular cAMP, produced in basal conditions and upon addition of receptorial and non-receptorial agonists, flows to the extracellular medium. In order to obtain insights about the mechanisms involved in this process, we used compounds able to influence both activity and expression of putative cyclic nucleotide transporters. To corroborate results obtained in HTR-8/SVneo cells, we also utilized JAR cells and human first-trimester placenta explants. The possible role of extracellular cAMP in the modulation of human trophoblast functions is discussed.
Materials and Methods

Chemicals
′ -monophosphate (specific activity 27 Ci/mmol) was purchased from Amersham Italia Srl (Milan, Italy). cAMP, isobutylmethylxanthine (IBMX), PGE 2 , FSK, probenecid, progesterone, cyclopentyladenosine (CPA), 4-aminobenzyl-5 ′ -N-methylcarboxamidoadenosine (AB-MECA), estrone, 1,3-dipropyl-8-p-sulphophenilxanthine (DPSPX), propidium iodide and Folin-Ciocalteu's phenol reagent were from Sigma Chemical Co. (St. Louis, MO). Ro 201724 and CGS 21 680 were purchased from Tocris (Avonmouth, UK). Interleukin (IL)-1b was from Endogen (Woburn, MA, USA). MK-571 was from Calbiochem (Germany). Tissue culture media, sera, RNA extraction and RT -PCR reagents were purchased from Invitrogen (Paisley, Scotland, UK). The rabbit polyclonal antiserum H-70 raised against amino acids 1 -70 of human MRP1 was from Santa Cruz Biotechnology (CA, USA). The mouse monoclonal antibody (mAb) QCRL-1 against human MRP1 (linear internal epitope S 918 SYSGDI 924 ) was from Alexis Biochemicals (Lausen, Switzerland). The mouse mAb MEM-G1 against recombinant human HLA-G denaturated heavy chain was from Exbio (Prague, Czech Rep.). The fluorescein isothiocyanate (FITC)-labeled affinity-purified goat anti-rabbit IgG serum and the Texas Red-labeled horse anti-mouse IgG serum were from Vector Laboratories (Burlingame CA, USA). qPCR human reference cDNA was purchased from Clontech Laboratories (Mountain View, CA, USA). All other chemicals were the highest reagent grades commercially available.
Cell cultures
The HTR-8/SVneo trophoblast cell line, obtained from human firsttrimester placental explant cultures and immortalized using SV40 large T antigen, was kindly provided by Dr. CH Graham, Queen's University, Kingston, Ontario (Canada). The human choriocarcinoma JAR cells were obtained from Istituto Zooprofilattico, Brescia (Italy). Cells were cultured at 378C in an atmosphere of 5% CO 2 /95% air in RPMI 1640 medium containing 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin.
Placental tissue
Placental tissue, obtained from a consenting patient undergoing spontaneous abortion at the 16th week of gestation, was fixed and utilized for immunohistochemistry. First-trimester placenta explants (n ¼ 3) were obtained from consenting patients undergoing elective termination of pregnancy (9-12 weeks of gestation) and freshly used for cAMP level determination.
cAMP level determination
Cells were grown to confluence (2-3 days), then the medium was removed and replaced by serum-free RPMI. The incubation was carried out in the absence or in the presence of phosphodiesterase (PDE) inhibitors and test substances, for the indicated times. Media were then collected and immediately frozen at 2708C until cAMP levels were measured. Ice-cold 0.1 N HCl (0.25 ml) was added to the cells and, after centrifugation at 12 500 × g for 10 min, supernatants were neutralized adding 0.5 M Trizma base (0.05 ml) and utilized for intracellular cAMP determination.
Placental explants were incubated in serum-free RPMI in the presence of 10 23 M IBMX and test substances for 60 min. Media were then collected and immediately frozen at 2708C until extracellular cAMP levels were measured. For intracellular cAMP determination, tissues were transferred to 5% cold trichloroacetic acid (0.5 ml) and maintained at 48C overnight. Samples were homogenized and centrifuged at 2000 × g for 10 min, then supernatants were utilized for cAMP determination after extraction with aqueous ethyl-ether. Intracellular and extracellular cAMP were measured by the method of Brown et al. (1972) and the nucleotide levels were expressed as pmoles /10 6 cells/time or as pmoles/mg protein/time. Protein content of placental explants was determined according to Lowry et al. (1951) on samples dissolved in 1 N NaOH. Assay sensitivity was 0.5 pmol/10 6 cells, and the intra-or inter-assay coefficients of variations were ,10%.
RT-PCR
RNA was extracted by a single-step guanidine thiocyanate method, using Trizol reagent, from HTR-8/SVneo cells (grown to 90% confluence). Total RNA was dissolved in diethyl pyrocarbonate-treated H 2 O and quantified by spectrophotometry. Three micrograms of total RNA was reversetranscribed using 200 units of Moloney murine leukemia virus reverse transcriptase and 1.5 mg of random primers, in a 20 ml reaction volume at 378C for 1 h. One microlitre was used as a template for PCR. The amplification reaction was performed using 0.5 units of Platinum Taq DNA polymerase in a 25 ml reaction volume containing 10 mM Tris -HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM dNTPs and 0.4 mM of each primer.
To check the RNA quality and quantity, RT-PCRs were performed using specific primers for 18S mRNA (Selvey et al., 2001) or ribosomal protein L 13A (RPL 13A) (Pattyn et al., 2006) , two constitutively expressed genes. PCR amplification from reverse transcribed cDNA was carried out using specific primers ( The PCR products were separated by electrophoresis on 2% (w/v) agarose gels containing 0.05% ethidium bromide using 100 bp DNA ladder as size marker. Relative amounts of amplification products were estimated by digital densitometry, using the 'Gel Doc 2000' video image system (Bio-Rad Laboratories, Hercules, CA).
Localization of MRP1 in cell lines
HTR-8/SVneo and JAR cells were incubated in serum-free medium for 24 h, then cells (1.5 × 10 6 /ml) were allowed to adhere onto glass coverslips overnight. Cell viability was checked by Trypan blue exclusion test before fixation. Adherent cells were prefixed with 1% paraformaldehyde (PFA) for 3 min, washed in phosphate-buffered salt solution (PBS; 0.01 M, pH 7.2) and labelled with the anti-human MRP1 rabbit polyclonal antiserum H-70 (200 mg/ml undiluted or 2 mg/ml diluted up to 1:100 in PBS-containing 0.05% BSA and 0.1% sodium azide) or the mouse mAb QCRL-1 (20 mg/ml undiluted) for 1 h at room temperature (RT) without any cell permeabilization. For double labelling experiments, the antiserum H-70 (diluted 1:10) was used together with the anti-human HLA-G mouse mAb MEM-G1 (diluted 1:100). Cells were then washed in PBS and incubated with FITC-labelled goat anti-rabbit IgG serum (diluted 1:100 in PBS) and/or Texas Red-labelled horse anti-mouse IgG serum (diluted 1:300 in PBS) for 1 h at RT in the dark. Controls included labelling with secondary antibodies alone in the absence of primary antibodies.
Cells were washed in PBS, post-fixed with 3% PFA for 3 min, rinsed in PBS, mounted in Vectashield (Vector) anti-fading in the dark and observed (FITC and Texas Red fluorescence excitation at 488 and 543 nm, respectively) with a laser scanning confocal microscope (LSCM; Carl Zeiss LSM 510, Arese, Italy) equipped with 40× and plan apochromat 63× oil immersion objectives and Argon/HeNE laser sources. Superimposition of red and green fluorescence, not specifically due to co-localization, was excluded by applying to the green channel a beam path admitting the acquisition of fluorescence between 505 and 550 nm and to the red channel a light path excluding all fluorescence ,560 nm. All images were obtained at an 8% laser potency and with pinhole diameters of 73 (40 × ) and 104 mm (63 × ). Amplifier and detector optimizing parameters were maintained constant for all the experiments. Digital magnification, cell and stacks dimension parameters were obtained with LSM confocal software (Zeiss).
In single labelling experiments with the anti-human MRP1 antiserum H-70, the nuclei of post-fixed HTR-8/SVneo and JAR cells were counterstained with propidium iodide (0.1 mM, 5 min in the dark).
Localization of MRP1 in human placenta
Freshly collected human placenta was fixed in Bouin's liquid for 7 h at 48C, dehydrated in graded cold ethanol series and embedded in paraffin wax. Serial sections of 7 mm thickness were de-waxed with toluene, rehydrated in graded cold ethanol series and put in 0.01 M, pH 7.2 PBS. Some sections were stained with Giemsa for general histology. Immunohistochemistry was performed by double immunofluorescence staining. Multiple sets of sections were placed in PBS containing 0.1% Triton X-100 for 30 min, washed in PBS and preincubated for 30 min with 5% normal human serum. Sections were then incubated overnight at 48C with the anti-human MRP1 rabbit polyclonal antiserum H-70 (diluted 1:10) and the anti-human HLA-G mouse mAb MEM-G1 (diluted 1:100). Primary antisera were diluted in PBS containing 0.05% BSA and 0.1% sodium azide. Negative controls were made by omission of the primary antibodies, or their substitution by normal rabbit and mouse sera. Serum prior rabbit immunization was used as a negative control for H-70 immunostaining. Thereafter, sections were washed in PBS and incubated for 1 h at RT in the dark with FITC-labelled goat anti-rabbit IgG serum (1:100) and Texas Red-labelled horse anti-mouse IgG serum (1:100). Secondary antisera were diluted in PBS containing BSA and sodium azide. Sections were washed in PBS, rinsed in distilled water, mounted in Vectashield anti-fading in the dark and observed with the LSCM, as described for cell lines.
Statistical analysis
Numerical results were analysed by ANOVA followed by Bonferroni's multiple comparison test, Dunnett's comparison post-test or two-tail Student's t-test, as appropriate, using the GraphPad Prism 2.1 software statistical package. The level for accepted statistical significance was P , 0.05. 6 cells, not shown). In the presence of PGE 2 or FSK, intracellular cAMP production increased as a function of incubation time up to 15 min (38-and 50-fold, respectively), thereafter a reduction of the nucleotide level was observed ( Fig. 1A and B) . A decrease of cAMP content due to its degradation appears unlikely since these experiments were carried out in the presence of 10 23 M IBMX, a broad spectrum inhibitor of cAMP PDE (Chiavegatti et al., 2008) . Therefore we evaluated the possibility of cAMP egress, quantifying the nucleotide concentration in the extracellular medium. In basal conditions the extracellular cAMP levels were similar to the intracellular ones and quite constant at all tested times (not shown). In the presence of PGE 2 or FSK, they progressively increased in a time-dependent fashion at least up to 60 min ( Fig. 1A and B) .
Results
In vitro experiments carried out in HTR-8/ SVneo cells
Effect of cAMP efflux inhibitors
We then tested the effect of progesterone and probenecid, two agents known to inhibit cyclic nucleotide efflux in several cell types (Florio et al., 1999; Godinho and Costa, 2003; Wielinga et al., 2003) , on cAMP levels stimulated by 10 26 M FSK or PGE 2 . After 60 min of incubation with FSK, both compounds significantly reduced (249%, P , 0.01 for progesterone; 262%, P , 0.01 for probenecid) extracellular cAMP concentration at the highest dose tested ( Fig. 2A) . Similar results were obtained in the presence of PGE 2 (260%, P , 0.01 for progesterone; 250%, P , 0.01 for probenecid) (Fig. 2B) . Otherwise, no significant alteration of the intracellular nucleotide level was found (not shown).
We then utilized MK-571, an inhibitor of MRP1 (Olson et al., 2001) , which is a well-characterized transporter in human placenta (Nagashige et al., 2003; Evseenko et al., 2006; Parry and Zhang, 2007) course experiments, an evident reduction of extracellular cAMP was found at all tested times ( Fig. 2C and D) , the maximal effect being observed after 60 min of incubation (272% for PGE 2 -and 251% for FSK-stimulated cAMP). In contrast, the intracellular cAMP concentrations did not vary significantly at any of the times tested ( Fig. 2C and D) .
Indirect immunofluorescence staining of MRP1
Cells were fixed and incubated with the antibodies raised against the human MRP1. Confocal microscopy was used to examine the plasma membrane versus intracellular localization of the immunostaining. A percentage of HTR-8/SVneo cells were labelled on plasma membrane by the anti-human MRP1 antibodies (Fig. 3A) . Interestingly, plasma membrane immunostaining was discretely localized in a pole of most positive cells (Fig. 3B) .
Effect of estrone and IL-1b treatment
Since it has been reported that mRNA expression for ABC transporters is modulated by cytokines and steroid hormones in human trophoblast (Evseenko et al., 2007; Keating et al., 2007) , we tested by RT -PCR the effect of a 24 h treatment with 10 26 M estrone and 10 ng/ml IL-1b, on MRP1 gene transcripts. Both estrone and IL-1b significantly enhanced (+61% and +55%, respectively, P , 0.001) the expression of MRP1 mRNA (Fig. 4A) . The effect of the same treatments was investigated also on intraand extra-cellular cAMP levels, stimulated by 10 26 M FSK or PGE 2 (Fig. 4B) . In both instances, the extracellular cAMP levels significantly increased after 60 min of treatment with estrone (+53% and +88% in the presence of FSK and PGE 2 , respectively) and IL-1b (+39% and +60% in the presence of FSK and PGE 2 , respectively). In all cases, the intracellular cAMP levels did not change significantly.
Analysis of exogenous cAMP degradation
To verify whether extracellular cAMP is metabolized by trophoblast cells, we added exogenous cAMP (100 pmoles/well) to the cell medium in the absence and in the presence of 10 24 M DPSPX, a selective inhibitor of ecto-PDE (Chiavegatti et al., 2008) ; in the collected medium we then determined cAMP level recovery after 15 min of incubation. As shown in Fig. 5 , in the absence of the drug a recovery of about 40% was obtained. This value significantly enhanced in the presence of DPSPX. 
Analysis of adenosine receptor expression and functionality
Evaluating the presence of mRNAs for adenosine receptor subtypes, we found transcripts for A 1 , A 2a , A 2b , but not for A 3 receptor. The commercially available human reference cDNA, used as positive control for A 3 receptor, showed a band of 440 bp corresponding to the amplification product of interest, under conditions used for HTR-8/SVneo cells (Fig. 6) . In order to verify the receptor functionality, we measured cAMP levels in cells incubated in the absence or in the presence of stable and selective agonists for the different adenosine receptor subtypes. Since IBMX is a known adenosine receptor antagonist (Wu et al., 1982) , we used 10 24 M Ro 20-1724 as cAMP PDE inhibitor. In Fig. 7 the dose -response curves for CPA and CGS 21 680, selective A 1 and A 2 receptor agonists respectively, are reported. CPA dose dependently inhibited basal and FSK-stimulated intracellular cAMP (Fig. 7A) . Its effect on FSK-stimulated cAMP levels reached statistical significance at 10 28 M and became maximal (274%) at 10 25 M. On the contrary, CGS 21 680 dose dependently stimulated the nucleotide production and its effect became statistically significant (+88%) at 10 26 M (Fig. 7B) . Coherently with the PCR results, the A 3 receptor agonist, AB-MECA, unaltered cAMP production (not shown).
In vitro experiments carried out in JAR cells
Intra-and extra-cellular cAMP levels
In JAR cells incubated up to 60 min, the basal intracellular cAMP levels did not significantly vary (around 9.0 pmoles/10 6 cells, not shown); in addition, 10 26 M FSK induced a stimulation reaching a maximum at 30 min (31-fold). The extracellular cAMP levels did not change significantly in basal conditions (not shown), whereas they linearly increased up to 60 min following FSK stimulation (Fig. 8A) . experiments, performed in duplicate on different cell cultures. *P , 0.05 with respect to PGE 2 or FSK alone; **P , 0.01 with respect to PGE 2 alone (two-way ANOVA followed by Bonferroni's multiple comparison test).
cAMP efflux from human trophoblast cells tested times (Fig. 8B) , the maximal effect being observed after 60 min of incubation (283%). The intracellular cAMP concentrations, instead, did not vary significantly (Fig. 8B ).
MRP1 indirect immunofluorescence staining
A significant percentage of JAR cells were evenly labelled on the membrane by the anti-human MRP1 antibodies (Fig. 8C) . Plasma membrane punctuate fluorescence can be appreciated by confocal imaging until 1:100 dilution of the antiserum H-70 (Fig. 8D ).
Ex vivo experiments carried out in human placenta
Intra-and extra-cellular cAMP levels
We utilized human first-trimester placental explants to measure intraand extra-cellular cAMP content after 60 min of incubation in the absence and in the presence of 10 26 M FSK. As shown in Fig. 9, upper panel, the diterpene significantly enhanced both intracellular (+177%) and extracellular (+53%) cAMP levels. When we added 10 25 M MK-571, a reduction of 247% of extracellular cAMP concentration was observed, whereas the intracellular one remained quite unchanged.
MRP1 immunohistochemistry
In order to confirm the expression of MRP1 in EVT cell population, we examined human decidua basalis from the 16th week of gestation (Fig. 9, lower panel) . Double immunostaining detected HLA-G positive EVT cells in the decidual tissue, most co-expressing MRP1 immunoreactivity (Fig. 9A -C) . HLA-G positive endovascular EVT cells also evidenced MRP1 co-expression, characterized by discrete localization of the antigens inside of the cells (Fig. 9D-F) . No labelling was detected in negative control sections (not shown).
Discussion
It has well been reported that cAMP is a second messenger highly involved in the modulation of human first-trimester trophoblast functions, including differentiation and secretion (Qu and Thomas, 1993; Bernatchez et al., 2003; Kudo et al., 2004) . Moreover, it has been implicated in the control of trophoblast cell proliferation, migration and invasiveness evoked by several agonists (Sawai et al., 1996; Zygmunt et al., 1998; McKinnon et al., 2001; Biondi et al., 2006 Biondi et al., , 2008 .
In the light of these observations and considering the growing evidence supporting a further role for the nucleotide in the extracellular compartment (Hofer and Lefkimmiatis, 2007) , we investigated whether a system able to extrude cAMP is present and functional in cells derived from first-trimester trophoblast. Immortalized or tumor cell lines derived from placenta are useful models to study the functions of such tissue, considering the difficulty to obtain human firsttrimester trophoblast primary cultures.
The data here reported indicate that, in HTR-8/SVneo cells, responses to PGE 2 and FSK are time-dependent: intracellular cAMP production reaches a maximum at 15 min and then decreases at least up to 60 min. Detectable nucleotide levels are present in the extracellular medium; in basal condition these are similar to the intracellular ones and almost constant at all tested times, as already demonstrated in other experimental models (Godinho and Costa, 2003) . In contrast, after stimulation, they linearly increase at least up to 60 min.
These results suggest that also in our model a cAMP efflux system is present and functional. To corroborate this hypothesis, we investigated whether extracellular cAMP levels are changed by high concentrations of progesterone and probenecid, notorious inhibitors of some ABC transporter subfamilies (Ueda et al., 1992; Schinkel and Jonker, 2003) . Results obtained demonstrate that both compounds significantly inhibit cAMP outflow after stimulation by PGE 2 and FSK. Among the probenecid-sensitive transporters the MRP subfamily, whose members are expressed in human placenta (St-Pierre et al., 2000; Nagashige et al., 2003; Evseenko et al., 2006) , seems to be particularly involved in cyclic nucleotide efflux. Thus, we utilized MK571, a known inhibitor of MRP subfamily, in particular of MRP1, to measure cAMP levels. The demonstration that this compound is able to remarkably inhibit cAMP outflow from stimulated trophoblast cells, supports a MRP1 role in the cyclic nucleotide efflux system. Moreover, estrone and IL-1b, two molecules produced by the feto-maternal unit and able to influence trophoblast functions, stimulate MRP1 expression and increase extracellular cAMP. In order to corroborate the presence of a cAMP efflux mechanism in the human trophoblast, some of the experiments have been carried out also in JAR cells, another common model of early human trophoblast as well as in placenta explants. Our demonstration that in these experimental models a MK571-sensitive cAMP efflux is present, further supports the existence of a mechanism able to extrude cAMP in the human trophoblast.
In both cell lines and placenta explants, all conditions altering efflux system functionality modify extracellular cAMP levels, but do not appreciably alter the intracellular ones, as observed by others (Ahlströ m and Lamberg-Allardt, 1999; Chiavegatti et al., 2008) . The existence of a compensatory mechanism involving the intracellular nucleotide synthesis/degradation balance may be suggested. cAMP efflux from human trophoblast cells plasma membrane is strongly supported by labelling of fixed, nonpermeabilized cells with specific antibodies against human MRP1.
Plasma membrane immunostaining was discretely localized in a pole of a percentage of HTR-8/SVneo cells, in keeping with the report, using a different experimental procedure, that only a fraction of such cells expresses MRP1 protein (Parry and Zhang, 2007) . Our double immunofluorescence experiments showed that HTR-8/SVneo cells (as the JAR cells) were HLA-G null, confirming a recent detailed analysis (Apps et al., 2009) ; therefore, putative HTR-8/SVneo subsets need to be characterized using other tools.
On the other hand, labelling by the MRP1 antibodies was seen on plasma membrane of most JAR cells, e.g. in a percentage apparently higher and at higher antibody dilutions compared with HTR-8/ SVneo cells. This MRP1 differential expression appears in keeping with the stronger inhibitory effect of MK571 on extracellular cAMP levels in JAR compared with HTR-8/SVneo cells. Double immunofluorescence staining confirmed the presence of MRP1 in EVT cells in the human decidua basalis, where the transporter is expressed by both interstitial and endovascular trophoblast cells that are HLA-G immunoreactive.
Extracellular cAMP function remains unclear, in particular in mammals. In fact its significance is known only in Dictyostelium discoideum, where the extracellular nucleotide serves as a chemical stimulus to promote aggregation of single-celled individuals (Hofer and Lefkimmiatis, 2007) . It has been proposed that cAMP efflux simply serves to reduce the cell cAMP concentration (Hofer and Lefkimmiatis, 2007) . Our data demonstrating intracellular cAMP steadiness though in the presence of an altered efflux, are not in line with this hypothesis, but support the idea that nucleotide egress could represent an additional arm of cAMP pathway able to evoke regulatory actions. Some experimental evidence indicates that a plausible physiological role for extracellular cAMP could involve adenosine formation. A regulation of different cell type secretion and proliferation mediated by this mechanism has been suggested (Dubey et al., 1996 (Dubey et al., , 2000 Jackson and Dubey, 2001) . A similar pathway could be operative also in the first-trimester human trophoblast. Indeed, at least in HTR-8/SVneo cells, ecto-PDE, the enzyme leading to 5 ′ AMP formation in the extracellular medium, is functional and 5 ′ nucleotidase, that metabolizes 5 ′ AMP to adenosine, is considered an ubiquitous enzyme (Cometti et al., 2003) . In addition these cells express adenosine receptor subtypes whose functionality is revealed by the ability of selective agonists to modulate intracellular cAMP levels. In the light of the above results we hypothesize that, also in trophoblast cells, adenosine formed by extracellular cAMP conversion could act in an autocrine or paracrine manner to finely modulate cAMP-dependent responses. Adenosine could also induce vasomotor effects in placental vessels where its receptors have been identified (Donoso et al., 2005) . In conclusion the data here reported demonstrate that, in HTR-8/ SVneo cell line, a cAMP system highly responsive to several cAMP efflux from human trophoblast cells modulators and an efficient nucleotide efflux mechanism are present. Among the transporters possibly implicated in cAMP outflow, an important role is likely played by MRP1 since both gene transcripts and protein are clearly detectable and extracellular cAMP levels are heavily affected by its inhibitor MK-571. In addition, MRP1 expression and functionality are modulated by factors, such as estrone and IL-1b, notoriously involved in the control of both physiological and pathological pregnancies, thus reinforcing the idea that MRP1 could play an important role in human trophoblast cAMP homeostasis. Considering the presence of functional adenosine receptors in HTR-8/SV neo cells, we propose that extracellular cAMP could play an important role through its conversion to adenosine (as demonstrated in several other tissues). Although we obtained evidence for the presence and functionality of cAMP extrusion system also in another trophoblast-derived cell line and in first-trimester human placenta explants, caution is needed when extrapolating results obtained in vitro to trophoblast tissue in vivo.
Further studies are required to investigate whether cAMP efflux modulates typical EVT cell functions, such as proliferation, migration and invasiveness. 
